Pituitary suppression before frozen embryo transfer is beneficial for patients suffering from idiopathic repeated implantation failure

Journal of Huazhong University of Science and Technology - Medical Science

Volumn 36, Issue 1, 2016, Pages 127-131

  Yang, Xing ^a   Huang, Rui ^a   Wang, Yan fang ^a   Liang, Xiao yan ^a  

^a THE SIXTH AFFILIATED HOSPITAL OF SUN YAT SEN UNIVERSITY   (China)

Author keywords

endometrium receptivity; gonadotrophin releasing hormone agonists; idiopathic repeated implantation failure; pituitary suppression

Indexed keywords

GONADORELIN; LHRH, ALA(6)-GLY(10)-ETHYLAMIDE-;

ADULT; ANALOGS AND DERIVATIVES; CLINICAL TRIAL; DRUG EFFECTS; EMBRYO TRANSFER; FEMALE; HORMONE SUBSTITUTION; HUMAN; HYPOPHYSIS; INTRACYTOPLASMIC SPERM INJECTION; NIDATION; PREGNANCY; PROCEDURES;

ADULT; EMBRYO IMPLANTATION; EMBRYO TRANSFER; FEMALE; GONADOTROPIN-RELEASING HORMONE; HORMONE REPLACEMENT THERAPY; HUMANS; PITUITARY GLAND; PREGNANCY; SPERM INJECTIONS, INTRACYTOPLASMIC;

EID: 84957103275     PISSN: 16720733     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11596-016-1554-2     Document Type: Article

References (39)

1. Raziel A, Friedler S, Schachter M, et al. Increased frequency of female partner chromosomal abnormalities in patients with high-order implantation failure after in vitro fertilization. Fertil Steril, 2002,78(3):515–519
2. Rubio C, Gil-Salom M, Simon C, et al. Incidence of sperm chromosomal abnormalities in a risk population: relationship with sperm quality and ICSI outcome. Hum Reprod, 2001,16(10):2084–2092
3. Voullaire L, Wilton L, McBain J, et al. Chromosome abnormalities identified by comparative genomic hybridization in embryos from women with repeated implantation failure. Mol Hum Reprod, 2002,8(11):1035–1041
4. Surrey ES. Impact of intramural leiomyomata on in-vitro fertilization-embryo transfer cycle outcome. Curr Opin Obstet Gynecol, 2003,15(3):239–242
5. Demirol A, Gurgan T. Effect of treatment of intrauterine pathologies with office hysteroscopy in patients with recurrent IVF failure. Reprod Biomed Online, 2004,8(5): 590–594
6. Costello MF, Lindsay K, McNally G. The effect of adenomyosis on in vitro fertilisation and intra-cytoplasmic sperm injection treatment outcome. Eur J Obstet Gynecol Reprod Biol, 2011,158(2):229–234
7. Hatasaka H. New perspectives for unexplained infertility. Clin Obstet Gynecol, 2011,54(4):727–733
8. Isaksson R, Tiitinen A. Present concept of unexplained infertility. Gynecol Endocrinol, 2004,18(5):278–290
9. Tan BK, Vandekerckhove P, Kennedy R, et al. Investigation and current management of recurrent IVF treatment failure in the UK. BJOG, 2005,112(6):773–780
10. Coughlan C, Ledger W, Wang Q, et al. Recurrent implantation failure: definition and management. Reprod Biomed Online, 2014,28(1):14–38
11. Cohen J, DeVane GW, Elsner CW, et al. Cryopreserved zygotes and embryos and endocrinologic factors in the replacement cycle. Fertil Steril, 1988,50(1):61–67
12. Oehninger S, Mayer J, Muasher S. Impact of different clinical variables on pregnancy outcome following embryo cryopreservation. Mol Cell Endocrinol, 2000,169 (1–2):73–77
13. de Ziegler D, Cornel C, Bergeron C, et al. Controlled preparation of the endometrium with exogenous estradiol and progesterone in women having functioning ovaries. Fertil Steril, 1991,56(5):851–855
14. Queenan Jr, Veeck LL, Seltman HJ, et al. Transfer of cryopreserved-thawed pre-embryos in a natural cycle or a programmed cycle with exogenous hormonal replacement yields similar pregnancy results. Fertil Steril, 1994,62(3): 545–550
15. Lin J, Sun C, Zheng H. Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis with infertility. Chin Med J (Engl), 2000,113(5):442–445
16. Silva PD, Perkins HE, Schauberger CW. Live birth after treatment of severe adenomyosis with a gonadotropin-releasing hormone agonist. Fertil Steril, 1994,61(1): 171–172
17. Surrey ES, Silverberg KM, Surrey MW, et al. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril, 2002,78(4): 699–704
18. Huang FJ, Kung FT, Chang SY, et al. Effects of short-course buserelin therapy on adenomyosis. A report of two cases. J Reprod Med, 1999,44(8):741–744
19. Devlieger R, D'Hooghe T, Timmerman D. Uterine adenomyosis in the infertility clinic. Hum Reprod Update, 2003,9(2):139–147
20. Niu Z, Chen Q, Sun Y, et al. Long-term pituitary downregulation before frozen embryo transfer could improve pregnancy outcomes in women with adenomyosis. Gynecol Endocrinol, 2013,29(12):1026–1030
21. Simon A, Hurwitz A, Zentner BS, et al. Transfer of frozen-thawed embryos in artificially prepared cycles with and without prior gonadotrophin-releasing hormone agonist suppression: a prospective randomized study. Hum Reprod, 1998,13(10):2712–2717
22. Tremellen K, Russell P. Adenomyosis is a potential cause of recurrent implantation failure during IVF treatment. Aust N Z J Obstet Gynaecol, 2011,51(3):280–283
23. Barnhart K, Dunsmoor-Su R, Coutifaris C. Effect of endometriosis on in vitro fertilization. Fertil Steril, 2002,77 (6):1148–1155
24. Kuivasaari P, Hippelainen M, Anttila M, et al. Effect of endometriosis on IVF/ICSI outcome: stage III/IV endometriosis worsens cumulative pregnancy and live-born rates. Hum Reprod, 2005,20(11):3130–3135
25. Kyama CM, Debrock S, Mwenda JM, et al. Potential involvement of the immune system in the development of endometriosis. Reprod Biol Endocrinol, 2003,Dec(1):123
26. Kissler S, Zangos S, Kohl J, et al. Duration of dysmenorrhoea and extent of adenomyosis visualised by magnetic resonance imaging. Eur J Obstet Gynecol Reprod Biol, 2008,137(2):204–209
27. Sallam HN, Garcia-Velasco JA, Dias S, et al. Long-term pituitary down-regulation before in vitro fertilization (IVF) for women with endometriosis. Cochrane Database Syst Rev, 2006:CD004635
28. Sharpe-Timms KL, Keisler LW, McIntush EW, et al. Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin-releasing hormone agonist therapy. Fertil Steril, 1998,69(6): 1128–1134
29. Ferrero S, Gillott DJ, Remorgida V, et al. Proteomic analysis of peritoneal fluid in fertile and infertile women with endometriosis. J Reprod Med, 2009,54(1):32–40
30. Ferrero S, Gillott DJ, Remorgida V, et al. GnRH analogue remarkably down-regulates inflammatory proteins in peritoneal fluid proteome of women with endometriosis. J Reprod Med, 2009,54(4):223–231
31. Wang J, Zhou F, Dong M, et al. Prolonged gonadotropin-releasing hormone agonist therapy reduced expression of nitric oxide synthase in the endometrium of women with endometriosis and infertility. Fertil Steril, 2006,85(4): 1037–1044
32. Lessey BA. Medical management of endometriosis and infertility. Fertil Steril, 2000,73(6):1089–1096
33. Ruan HC, Zhu XM, Luo Q, et al. Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin beta3 and leukaemia-inhibitory factor and improves uterine receptivity in mice. Hum Reprod, 2006,21(10):2521–2529
34. Kdous M, Chaker A, Bouyahia M, et al. Increased risk of early pregnancy loss and lower live birth rate with GNRH antagonist vs. long GNRH agonist protocol in PCOS women undergoing controlled ovarian hyperstimulation. Tunis Med, 2009,87(12):834–842
35. Kwak-Kim JY, Chung-Bang HS, Ng SC, et al. Increased T helper 1 cytokine responses by circulating T cells are present in women with recurrent pregnancy losses and in infertile women with multiple implantation failures after IVF. Hum Reprod, 2003,18(4):767–773
36. Younis A, Hawkins K, Mahini H, et al. Serum tumor necrosis factor-alpha, interleukin-6, monocyte chemotactic protein-1 and paraoxonase-1 profiles in women with endometriosis, PCOS, or unexplained infertility. J Assist Reprod Genet, 2014,31(11):1445–1451
37. Ledee-Bataille N, Bonnet-Chea K, Hosny G, et al. Role of the endometrial tripod interleukin-18,-15, and-12 in inadequate uterine receptivity in patients with a history of repeated in vitro fertilization-embryo transfer failure. Fertil Steril, 2005,83(3):598–605
38. van Gestel I, MM IJ, Hoogland HJ, et al. Endometrial wave-like activity in the non-pregnant uterus. Hum Reprod Update, 2003,9(2):131–138
39. Urman B, Ata B, Yakin K, et al. Luteal phase empirical low molecular weight heparin administration in patients with failed ICSI embryo transfer cycles: a randomized open-labeled pilot trial. Hum Reprod, 2009,24(7): 1640–1647